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1. Introduction 
Protein A24 is a conjugate of histone H2A and 
ubiquitin [ 11. It is present in nucleosomes and repre- 
sents -2% of the histone content of core nucleosomes 
where it substitutes for H2A [2-41. Decreases in pro- 
tein A24 have been seen following thioacetamide 
treatment [S] or partial hepatectomy [6] and noted 
in transcriptionally active rat liver chromatin [7]. 
Protein A24 disappears from cells entering mitosis, 
thus revealing that ubiquitin must be released prior 
to chromatin condensation [ 8,9]. An enzymatic activ- 
ity has been found that cleaves protein A24 into his- 
tone H2A and ubiquitin [ 10-121. 
Here, acid-soluble nuclear proteins from Ehrlich 
ascites tumor cells treated with nitrosoureas have 
been investigated. In all experiments considerable 
changes in only one acidextracted chromatin protein 
were found when analyzed by polyacrylamide gel 
electrophoresis. Due to its extraction in 0.4 N H$SOa, 
its M,-value, position on two-dimensional gels, and 
elution characteristics on blue Sepharose, this protein 
has been identified as A24. Densiometric analysis of 
onedimensional gels revealed that protein A24 
increased in a dose-dependent manner following treat- 
ment of Ehrlich ascites cells with 1 -methyl-l -nitro- 
sourea and 1,3-bis(2-chloroethyl).1 -nitrosourea, even 
though protein synthesis was totally inhibited. 
2. Materials and methods 
1,3-Bis(2-chloroethyl)-l-nitrosourea (BCNU) was 
obtained from the Drug Research and Development 
Program (National Cancer Institute, National Institute 
of Health, Bethesda MD). 1-Methyl-I-nitrosourea 
(MNU) was purchased from ICN Pharmaceuticals. 
Ehrlich ascites tumor cells adapted to suspension cul- 
ture were kept in exponential growth by daily dilution 
with Eagle’s minimum essential medium with Earle’s 
salts supplemented with 10% heat-inactivated fetal 
calf serum, 100 units/ml benzyl penicillin, 100 ,ug/ml 
streptomycin, N-2-hydroxyethylpiperazine-N’-2- 
ethanesulfonic acid (Hepes) buffer (pH 7.3) to 15 mM 
final cont. and nonessential amino acids. Cells were 
exposed to drugs for 1 h, at 37°C with appropriate 
controls. Nuclei from control and drug-treated cells 
were isolated by gentle hypotonic homogenization. 
After restoring isotonicity the remaining cytoplasm 
was removed with Triton X-100 in isotonic buffer 
[ 131. Nuclear proteins were extracted twice with 
0.4 N HzS04 at -5 X 10’ nuclei/ml. Proteins were 
recovered by precipitation with 8 vol. acetone. 
Polyacrylamide gel electrophoresis was carried 
out in SDS gels according to [ 141. Two-dimensional 
gel electrophoresis was performed as in [ 15 1. Acid- 
soluble nuclear proteins were chromatographed on 
blue Sepharose CLdB (Pharmacia) as in [ 16 ] and 
fractions analyzed by one-dimensional gel electro- 
phoresis as above. Gels were stained with Coomassie 
blue and scanned at 600 nm using a Gilford linear 
transport spectrophotometer. 
3. Results and discussion 
Fig.1 shows a one-dimensional SDS gel containing 
acid-soluble nuclear proteins from BCNU-treated 
Ehrlich ascites cells. The protein band marked A24 
has iVfr 27 000 and was barely visible in control cell 
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Fig.1. 7.5% polyacrylamide-SDS gel electrophoresis of 0.4 
N H,SO, soluble nuclear proteins. Electrophoresis was done 
as in [ 141. Left: Ehrlich ascites tumor cells were incubated 
with 50 pg BCNU/ml for 1 h at 37°C. Right: Pharmacla low 
M, calibration proteins;M,-values are indicated. 
preparations. ThisM, for protein A24 agrees well with 
PI. 
Increases in protein A24 following nitrosourea 
treatment are indicated in table 1. As can be seen, 
these increases in protein A24 relative to the sum of 
the core histones appear to be dose-dependent. Treat- 
ment of Ehrlich ascites cells with BCNU led to -250% 
higher amounts of A24 than in control cells as judged 
by densiometric scanning while MNU treatment 
resulted in even larger increases. Table 1 also shows 
that A24 constituted 3.6% of the core histones in 
Ehrlich ascites cells, this value being somewhat higher 
than in [2,9]. 
Increases in protein A24 were also demonstrated 
by twodimensional gel electrophoresis as illustrated 
in fig.2. The enlarged protein spot corresponding to 
the position of A24 in [2,3,15] seen after BCNU- 
treatment of cells (fig2A) was not affected by the 
simultaneous presence of puromycin (20 E.cg/rnl) 
during drug treatment (not shown). This indicates 
that protein synthesis cannot be responsible for the 
larger amounts of protein A24 seen following nitro- 
sourea treatment. 
Greater amounts of A24 from nitrosourea-treated 
cells were also detected when fractions of acid-soluble 
Table 1 
Increases in protein A24 following nitrosourea treatment 
Drug treatment Ratio A241 
core histones 
% Control 
Control 0.0366 100 
BCNU (10 ,ug/ml) 0.0601 163 
BCNU (25 pg/ml) 0.0762 208 
BCNU (50 I.rg/ml) 0.0904 247 
MNU (100 gg/ml) 0.0751 205 
MNU (200 fig/ml) 0.1126 307 
Ehrlich ascites cells were treated for 1 h at 37’C with the 
indicated concentrations of drugs. The nuclei were subse- 
quently isolated and the acid-soluble proteins extracted with 
0.4 N H,SO,. Proteins were separated on 15% polyacryl- 
amide-SDS gels, stained with Coomassie brilliant blue, and 
densiometric scans made at 600 nm. The ratio of protein A24 
to core histones (H2A, H2B, H3, H4) was determined by 
weighing the areas under the protein peaks. Results represent 
the average of 2 determinations 
nuclear proteins chromatographed on blue Sepharose 
were analyzed by polyacrylamide gel electrophoresis. 
A24 consistently eluted together with histones H2A 
and H2B demonstrating that its affinity for blue 
Sepharose is identical with H2A and not affected by 
the isopeptide linkage to ubiquitin (not shown). 
There are 3 possible ways in which nitrosoureas 
could cause the apparent increases in protein A24. 
(1) 
(2) 
(3) 
Alkylation by BCNU and MNU could change the 
structure of protein A24 and prevent its cleavage 
mediated by A24 lyase. Another alkylating agent, 
nitrogen mustard, at up to 100 /.fg/rnl does not 
induce increases in protein A24 (not shown). 
Any changes in protein A24 due to alkylation are 
thus not sufficient to affect its turnover. 
Crosslinking of DNA could prevent A24 cleavage. 
Since A24 is an integral part of nucleosomes, 
cross-linking of DNA by BCNU could hinder A24 
from being cleaved by A24 lyase. However, results 
with nitrogen mustard (which is also able to cross- 
link DNA) do not support this reasoning. Further- 
more MNU does not crosslink DNA but induces 
large amounts of A24 within the 1 h treatment 
period. 
There is the possibility that A24 lyase, the 
enzyme responsible for cleavage of protein A24, 
may be inhibited in nitrosourea-treated cells. 
Nitrosoureas decompose to form carbamoylating 
breakdown products [ 17 ,181. The 2chloroethyl 
isocyanate product of BCNU degradation has 
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Fig.2. Twodimensional polyacrylamide gel electrophoresis of 0.4 N H,SO, soluble nuclear proteins from Ehrlich ascites tumor 
cells. The first dimension is acetic acid/urea (right-to-left) and the second is SDS (top-to-bottom) as in [ 151. (A) Cells treated with 
50 pg BCNU/ml for 1 h at 37°C; 120 rg protein applied. (B) Control cells, non-treated; 150 fig protein applied. 
been shown to inhibit DNA polymerase [ 19,201 
and ligase [21]. A very rapid turnover of ubi- 
quitin-histone conjugates was shown in [22,23]. 
The formation and dissociation of A24 appears 
to be a fast process. Inhibition of the cleavage 
step by MNU or BCNU would therefore lead to a 
rapid increase in protein A24 and may represent 
a valid interpretation of these results. 
The results presented here are of importance in 
that this is the first example of increases in protein 
A24. Treatment of cells with alkylating agents may 
help to elucidate the function of the cleavage nzyme 
A24 lyase. Furthermore, the action of alkylating 
agents on the structure of chromatin may have rele- 
vance to the further understanding of the role of A24 
in nucleosome structure and function. 
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